Pulmonary embolism in obesity-hypoventilation syndrome.
enlarged pulmonary artery
obesity-hypoventilation syndrome
pulmonary embolism
Journal
The clinical respiratory journal
ISSN: 1752-699X
Titre abrégé: Clin Respir J
Pays: England
ID NLM: 101315570
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
01
08
2019
revised:
14
07
2020
accepted:
27
07
2020
pubmed:
4
8
2020
medline:
19
8
2021
entrez:
4
8
2020
Statut:
ppublish
Résumé
Obesity-hypoventilation syndrome occurs with alveolar hypoventilation during sleeping and daytime. Obesity may be a risk factor for venous thromboembolism. However, the venous thromboembolism in the obesity-hypoventilation syndrome is not well characterized. This case series aimed to investigate the presence and clinical features of venous thromboembolism in patients with the obesity-hypoventilation syndrome. Data of eight case reports were collected. Ages ranged from 36 to 73 years. All patients had mosaic perfusion and enlarged main pulmonary artery, two had signs of infarction and mostly segmental and subsegmental filling defects. On the basis of this information some conclusions can be drawn carefully. Present cases indicate that pulmonary embolism are also very common in patients with obesity-hypoventilation syndrome, anticoagulant therapy is at least as important as the treatment of the current disease. Clinicians will frequently be faced with patients with obesity-hypoventilation syndrome suspected of PE.
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1099-1104Informations de copyright
© 2020 John Wiley & Sons Ltd.
Références
Almeneessier AS, Nashwan SZ, Al-Shamiri MQ, et al. The prevalence of pulmonary hypertension in patients with obesity hypoventilation syndrome: a prospective observational study. J Thorac Dis. 2017;9(3):779-788.
Iftikhar IH, Roland J. Obesity hypoventilation syndrome. Clin Chest Med. 2018;39(2):427-436. https://doi.org/10.1016/j.ccm.2018.01.006
Goichot B, Grunebaum L, Desprez D, et al. Circulating procoagulant microparticles in obesity. Diab Metab. 2006;32(1):82-85.
Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med. 2005;118(9):978-980.
Steffen LM, Cushman M, Peacock JM, et al. Metabolic syndrome and risk of venous thromboembolism: longitudinal investigation of thromboembolism etiology. J Thromb Haemost. 2009;7(5):746-751. https://doi.org/10.1111/j.1538-7836.2009.03295.x
Horvei LD, Braekkan SK, Hansen JB. Weight change and risk of venous thromboembolism: the tromsø study. PLoS ONE. 2016 20;11(12):e0168878. https://doi.org/10.1371/journal.pone.0168878
Eichinger S, Hron G, Bialonczyk C, et al. Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med. 2008 11;168(15):1678-1683. https://doi.org/10.1001/archinte.168.15.1678
Mueller C, Limacher A, Méan M, Rodondi N, Aujesky D. Obesity is not associated with recurrent venous thromboembolism in elderly patients: results from the prospective SWITCO65+ cohort study. PLoS ONE. 2017 15;12(9):e0184868. https://doi.org/10.1371/journal.pone.0184868.
Balachandran JS, Masa JF, Mokhlesi B. Obesity hypoventilation syndrome epidemiology and diagnosis. Sleep Med Clin. 2014;9(3):341-347. https://doi.org/10.1016/j.jsmc.2014.05.007
Masa JF, Pépin JL, Borel JC, Mokhlesi B, Murphy PB.Sánchez-Quiroga MÁ. Obesity hypoventilation syndrome. Eur Respir Rev. 2019 Mar 14;28(151):180097. https://doi.org/10.1183/16000617.0097-2018.
Melinek J, Livingston E, Cortina G, Fishbein MC. Autopsy findings following gastric bypass surgery for morbid obesity. Arch Pathol Lab Med. 2002;126(9):1091-1095.
Horvei LD, Braekkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Hansen JB. Obesity measures and risk of venous thromboembolism and myocardial infarction. Eur J Epidemiol. 2014 Nov;29(11):821-830. https://doi.org/10.1007/s10654-014-9950-z
Friedman SE, Andrus BW. Obesity and pulmonary hypertension: a review of pathophysiologic mechanisms. J. Obes. 2012; 505274. https://doi.org/10.1155/2012/505274
Basili S, Pacini G, Guagnano MT, et al. Insulin resistance as a determinant of platelet activation in obese women. J Am Coll Cardiol. 2006;48:2531-2538.
Mertens I, Van Gaal LF. Obesity, haemostasis and the fibrinolytic system. Obes Rev. 2002;3:85-101.
Rizkallah J, Man SF, Sin DD. Prevalence of pulmonaryembolism in acute exacerbations of chronic obstructive pulmonarydisease: a systematic review and meta-analysis. Chest. 2009;135(3):786-793.
Sabit R, Thomas P, Shale DJ, Collins P, Linnane SJ. The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD. Chest. 2010;138(1):47-51. https://doi.org/10.1378/chest.09-2764
Kauppert CA, Dvorak I, Kollert F, et al. Pulmonary hypertension in obesity-hypoventilation syndrome. Respir Med. 2013;107(12):2061-2070. https://doi.org/10.1016/j.rmed.2013.09.017
De Monyé W, Sanson BJ, Mac Gillavry MR, et al. ANTELOPE-Study Group. Embolus location affects the sensitivity of a rapid quantitative D-dimer assay in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med. 2002 1;165(3):345-348.
Hawley PC, Hawley MP. Difficulties in diagnosing pulmonary embolism in the obese patient: a literature review. Vasc Med. 2011;16(6):444-451. https://doi.org/10.1177/1358863X11422571